Seattle Genetic sees Q2 loss of $85M
BOTHELL (AP) Seattle Genetics Inc. (SGEN) on Thursday reported a loss of $84.6 million in its second quarter.
The Bothell-based company said it had a loss of 47 cents per share.
Global Anti-CD19 Therapeutic Antibody Market Study Offering Insights on Latest Advancements, Trends pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Acumen Research and Consulting, a global provider of market research studies, has recently published a report titled “Brain Metastasis Therapeutic Market –.
/Global Anti-CD19 Therapeutic Antibody Market Is Set for a Potential Growth Worldwide ||Bristol-Myers Squibb Company, Affimed GmbH, Bio-Rad Laboratories, Inc., Bayer AG, Bellicum Phamaceuticals, Inc
Global Anti-CD19 Therapeutic Antibody Market Is Set for a Potential Growth Worldwide ||Bristol-Myers Squibb Company, Affimed GmbH, Bio-Rad Laboratories, Inc., Bayer AG, Bellicum Phamaceuticals, Inc 1
Global anti-CD19 therapeutic antibody market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing with the healthy CAGR in the above-mentioned forecast period. Factors such as growing prevalence of acute leukemia cases and autoimmune diseases are responsible for the growth of anti-CD19 therapeutic antibody market globally. Moreover, increasing number of research grants and activities in this field can also boost the growth of this market.